Search

Your search keyword '"Fuchs, Michael"' showing total 158 results

Search Constraints

Start Over You searched for: Author "Fuchs, Michael" Remove constraint Author: "Fuchs, Michael" Publisher elsevier bv Remove constraint Publisher: elsevier bv
158 results on '"Fuchs, Michael"'

Search Results

1. Involved-site radiotherapy is equally effective and less toxic than Involved-field radiotherapy in patients receiving combined modality treatment for early-stage unfavorable Hodgkin lymphoma - an analysis of the randomized phase III HD17 trial of the German Hodgkin Study Group

3. The Impact of Stigma on Quality of Life and Liver Disease Burden Among Patients with Nonalcoholic Fatty Liver Disease

6. A global research priority agenda to advance public health responses to fatty liver disease

8. Stigma in NAFLD and NASH: a global survey of patients and providers

9. Substitution of even one non-vegetarian meal with plant-based alternatives associate with lower ammoniagenesis in patients with cirrhosis who follow a western diet: a randomized clinical trial

12. Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease

13. Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era

14. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study

15. International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

27. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States

29. Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial

30. Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis

31. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial

34. Su351 LIVER-UNRELATED COMORBID CONDITIONS DO NOT AFFECT THE DEVELOPMENT OF OVERT HEPATIC ENCEPHALOPATHY

37. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

40. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

41. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy

42. Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition

44. Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis

47. Gut microbiota are associated with minimal hepatic encephalopathy (MHE) in cirrhosis regardless of country of origin

48. Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the U.S. is cost effective: A comprehensive economical analysis

49. Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

50. Fecal microbial transplant reduces short-term cravings, improves quality of life and microbial diversity in cirrhosis and alcohol use disorder: a randomized, placebo-controlled, clinical trial

Catalog

Books, media, physical & digital resources